Neonatal G6PD
Accurate Enzymatic Screening for G6PD Deficiency in Newborns A precise and reliable fluorometric assay for the quantitative determination of glucose-6-phosphate dehydrogenase (G6PD) activity from dried blood spots.
Overview
Labsystems Diagnostics Neonatal G6PD assay enables early detection of G6PD deficiency, one of the most common enzymatic disorders in newborns. Using a fluorometric enzymatic method, it provides quantitative measurement of G6PD activity from dried blood spot samples with high accuracy and reproducibility. This assay supports large-scale newborn screening programs with minimal turnaround time and dependable results, ensuring prompt clinical intervention where required.
Key Features
- Enzymatic fluorometric assay for G6PD activity
- Designed for use with dried blood spot samples
- High reproducibility and assay stability
- Short assay time — results within 30 minutes
- Excellent correlation with external quality controls
Technical Specifications
- Format : 10 solid plates (96 wells each)
- Total Wells : 960
- Catalogue Number : 6199860
IS Modules
- Consistent performance across multiple batches
- Compatible with Labsystems newborn screening workflow
- Designed to integrate seamlessly into automated systems
- Ensures traceability and data accuracy throughout the screening process